7NR8

Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2

Summary for 7NR8

Entry DOI	10.2210/pdb7nr8/pdb
Related	7NQQ 7NQW 7NR3 7NRS
Descriptor	Mitogen-activated protein kinase 1, SULFATE ION, DIMETHYL SULFOXIDE, ... (6 entities in total)
Functional Keywords	serine/threonine kinase, signal transduction, map kinase, atp-binding protein, signaling protein
Biological source	Homo sapiens (Human)
Total number of polymer chains	1
Total formula weight	43771.73
Authors	O'Reilly, M.,Cleasby, A. (deposition date: 2021-03-03, release date: 2021-10-06)
Primary citation	Heightman, T.D.,Berdini, V.,Bevan, L.,Buck, I.M.,Carr, M.G.,Courtin, A.,Coyle, J.E.,Day, J.E.H.,East, C.,Fazal, L.,Griffiths-Jones, C.M.,Howard, S.,Kucia-Tran, J.,Martins, V.,Muench, S.,Munck, J.M.,Norton, D.,O'Reilly, M.,Palmer, N.,Pathuri, P.,Peakman, T.M.,Reader, M.,Rees, D.C.,Rich, S.J.,Shah, A.,Wallis, N.G.,Walton, H.,Wilsher, N.E.,Woolford, A.J.,Cooke, M.,Cousin, D.,Onions, S.,Shannon, J.,Watts, J.,Murray, C.W. Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J.Med.Chem., 64:12286-12303, 2021 Cited by PubMed: 34387469 DOI: 10.1021/acs.jmedchem.1c00905 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.627 Å)

Structure validation